Retroperitoneal Inflammation Detected on FDG PET/CT in Patient on Long-Term Immunotherapy
Authors:
- 1 February 2023
- journal article
- editorial
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 48 (4) , e165-e166
Abstract
A 68-year-old man with a history of pulmonary adenocarcinoma on maintenance pembrolizumab presented for surveillance imaging. 18F-FDG PET/CT demonstrated new ill-defined right retroperitoneal and presacral soft tissue stranding with associated FDG uptake suggestive of inflammation. Biopsy results revealed fibroadipose tissue with extensive lymphoplasmacytic inflammation concerning for immunotherapy-related toxicity. The patient was subsequently taken off pembrolizumab, which he had been on for approximately 3 years. Recognition of immunotherapy-related adverse effects and how they can manifest on 18F-FDG PET/CT is important for prompt cessation of treatment.Keywords
This publication has 10 references indexed in Scilit:
- Nivolumab Immunotherapy–Related Skin Reactions Detected on 18F-FDG PET/CT in Renal Cell CancerClinical Nuclear Medicine, 2022
- 18F‐FDG PET/CT features of immune‐related adverse events and pitfalls following immunotherapyJournal of Medical Imaging and Radiation Oncology, 2022
- 18F-FDG PET/CT Imaging of Immune Checkpoint Inhibitor–Related “Retroperitoneal Panniculitis”Clinical Nuclear Medicine, 2021
- Immunotherapy-Related Imaging Findings in Patients with Gynecological Malignancies: What Radiologists Need to KnowKorean Journal of Radiology, 2021
- FDG PET/CT for Assessment of Immune Therapy: Opportunities and Understanding PitfallsSeminars in Nuclear Medicine, 2020
- Pembrolizumab-Induced Thyroiditis and Colitis—Presentation and Resolution on Serial FDG PET/CTClinical Nuclear Medicine, 2020
- 18F-Fludeoxyglucose PET/Computed Tomography for Assessing Tumor Response to Immunotherapy and Detecting Immune-Related Side EffectsPET Clinics, 2020
- Retroperitoneal fibrosis in on-going anti-PD-1 immunotherapy detected with [18F]-FDG PET/CTEuropean Journal of Nuclear Medicine and Molecular Imaging, 2019
- Detection of immune-related adverse events by medical imaging in patients treated with anti-programmed cell death 1European Journal of Cancer, 2018
- Radiologic Manifestations of Immune-Related Adverse Events in Patients With Metastatic Melanoma Undergoing Anti–CTLA-4 Antibody TherapyAmerican Journal of Roentgenology, 2011